Form 4 for MYGN MYRIAD GENETICS INC
Accepted 2025-09-22 00:00:00 ET · period of report 2025-09-21 · accession 0001843568-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-22 | 2025-09-21 | MYGN | Ancona Margaret | EVP, Strategy, Transformation | F - Tax | $7.77 | -958 | 127.7K | -0.7% | -$7,444 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-21 | F | D | 958 | $7.77 | 127,726 | D | — | — | (F1) Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person. The number of shares of Myriad common stock withheld was determined based on the closing price of Myriad common stock on September 19, 2025. |